We are live on ! Find out more
TIL icon

Instil Bio
TIL

30 hedge funds and large institutions have $30M invested in Instil Bio in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

57.55% more ownership

Funds ownership: 3.08% → 60.64% (+58%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

13% less capital invested

Capital invested by funds: $34.3M → $30M (-$4.3M)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

48% less funds holding

Funds holding: 58 → 30 (-28)

93% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 30

Holders
30
Holders Change
-28
Holders Change %
-48.28%
% of All Funds
0.44%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
9
Reduced
16
Closed
30
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$559K
2
Renaissance Technologies
Renaissance Technologies
New York
+$444K
3
Citadel Advisors
Citadel Advisors
Florida
+$188K
4
AFM
Anson Funds Management
Texas
+$125K
5
Squarepoint
Squarepoint
New York
+$99K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$2.01M
2
WSL
Western Standard LLC
California
-$769K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$371K
4
Millennium Management
Millennium Management
New York
-$285K
5
BlackRock
BlackRock
New York
-$219K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$99 -$7 -1 -7%
Citigroup
27
Citigroup
New York
$15 -$615 -85 -98%
Bank of America
28
Bank of America
North Carolina
$15 -$333 -46 -96%
BBA
29
Baker Bros. Advisors
New York
– -$2.01M -235,220 Closed
WSL
30
Western Standard LLC
California
– -$769K -89,849 Closed
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
– -$371K -43,364 Closed
Barclays
32
Barclays
United Kingdom
– -$151K -17,652 Closed
IC
33
IEQ Capital
California
– -$51.4K -6,000 Closed
Northern Trust
34
Northern Trust
Illinois
– -$45.5K -5,315 Closed
LFCM
35
Long Focus Capital Management
Puerto Rico
– -$42.8K -5,000 Closed
HWAM
36
Hennion & Walsh Asset Management
New Jersey
– -$42K -4,904 Closed
BPA
37
Beacon Pointe Advisors
California
– -$41.5K -4,850 Closed
Tudor Investment Corp
38
Tudor Investment Corp
Connecticut
– -$27.3K -3,193 Closed
Charles Schwab
39
Charles Schwab
California
– -$25.5K -2,981 Closed
BCM
40
Bridgeway Capital Management
Texas
– -$25.5K -2,975 Closed
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
– -$21.5K -2,525 Closed
TSS
42
Two Sigma Securities
New York
– -$17.8K -2,085 Closed
HWA
43
HCR Wealth Advisors
California
– -$17.1K -2,000 Closed
Jane Street
44
Jane Street
New York
– -$17K -1,987 Closed
LCM
45
Landscape Capital Management
New Jersey
– -$16.4K -1,912 Closed
Goldman Sachs
46
Goldman Sachs
New York
– -$13.6K -1,586 Closed
Assenagon Asset Management
47
Assenagon Asset Management
Luxembourg
– -$12.8K -1,493 Closed
Bank of New York Mellon
48
Bank of New York Mellon
New York
– -$11.1K -1,300 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$10.7K -1,252 Closed
Stifel Financial
50
Stifel Financial
Missouri
– -$7.06K -825 Closed
1
2
3

TIL Hedge Fund Activity: Q4 2023 in Review

30 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q4 2023, worth a combined $30M — down 13% from $34.3M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of TIL and 2 opened new positions — a net loss of 28 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Nantahala Capital Management, adding an estimated $559K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $2.01M sold.

  • 30 institutional investors held Instil Bio (TIL) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $30M of Instil Bio stock for Q4 2023, down 13% quarter-over-quarter.
  • 2 funds opened new Instil Bio positions in Q4 2023 and 30 closed out, a net change of -28 holders.
  • The largest Instil Bio buyer in Q4 2023 was Nantahala Capital Management, an estimated $559K added.
  • The largest Instil Bio seller in Q4 2023 was Baker Bros. Advisors, an estimated $2.01M sold.

Based on aggregated 13F filings for Q4 2023.